Abstract:Microglia as an important type of innate immune cell in the brain have been considered as an effective therapeutic target for the treatment of central nervous degenerative diseases. Herein, we report cell membrane coated novel biomimetic Cu<sub>2–<i>x</i></sub>Se-PVP-Qe nanoparticles (denoted as nanoparticles, where PVP is poly(vinylpyrrolidone), Qe is quercetin, and CM is the cell membrane of neuron cells) for effectively targeting and modulating microglia to treat Parkinson's disease (PD). The CSPQ nanoparticles exhibit multienzyme activities and could effectively scavenge the reactive oxygen species and promote the polarization of microglia into the anti-inflammatory M2-like phenotype to relieve neuroinflammation. We reveal that biomimetic nanoparticles targeted microglia through the specific interactions between the membrane surface vascular cells adhering to molecule-1 and α4β1 integrin expressed by microglia. They could significantly improve the symptoms of PD mice to result in an excellent therapeutic efficacy, as evidenced by the recovery of their dopamine level in cerebrospinal fluid, tyrosine hydroxylase, and ionized calcium binding adapter protein 1 to normal levels. Our work demonstrates the great potential of these robust biomimetic nanoparticles in the targeted treatment of PD and other central nervous degenerative diseases.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c09390?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c09390</a>.Additional information including materials, synthesis, and characterization assay of enzymatic activity and ROS scavenging capacity of QP complex, CSP, and CSPQ nanoparticles (TEM, particle size distribution, TGA, ESR, reaction mechanism of enzyme activity detection; ζ potential; CLSM images and FCAS of intracellular ROS level); immunofluorescence staining of β1 integrins in BV2 cells; PA images and signals intensities of the brain after intravenous injection with nanoparticles; photograph of brain slice stained with rubeanic acid; H&E images of major organs (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c09390/suppl_file/ja0c09390_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A STIR Nucleic Acid Drug Delivery System for Stirring Phenotypic Switch of Microglia in Parkinson’s Disease Treatments

A STIR nucleic acid drug delivery system for stirring phenotypic switch of microglia in Parkinson's disease treatments

An Antisense Oligonucleotide-Loaded Blood–Brain Barrier Penetrable Nanoparticle Mediating Recruitment of Endogenous Neural Stem Cells for the Treatment of Parkinson’s Disease

Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model

Delivery of Small Interfering RNA by Hydrogen Sulfide-Releasing Nanomotor for the Treatment of Parkinson's Disease

Targeting Microglia for Therapy of Parkinson’s Disease by Using Biomimetic Ultrasmall Nanoparticles

A Dual Synergetic Nanoreactor for Managing Parkinson's Disease by Regulating Inflammation and Mitigating Oxidative Damage

Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson's Disease

Brain delivery of fibronectin through bioactive phosphorous dendrimers for Parkinson's disease treatment via cooperative modulation of microglia

Brain-targeted Gene Delivery of ZnO Quantum Dots Nanoplatform for the Treatment of Parkinson Disease

Single-atom Nanozyme Liposome-Integrated Microneedles for in Situ Drug Delivery and Anti-Inflammatory Therapy in Parkinson’s Disease

Single-atom nanozyme liposome-integrated microneedles for in situ drug delivery and anti-inflammatory therapy in Parkinson's disease

Synthesis Of Double Interfering Biodegradable Nano-Mgo Micelle Composites And Their Effect On Parkinson'S Disease

Engineered Extracellular Vesicle-Based Nanoformulations That Coordinate Neuroinflammation and Immune Homeostasis, Enhancing Parkinson's Disease Therapy

Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer's disease and Parkinson's disease

"Swiss Army Knife" black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment

Targeting the Pathogenesis and Boosting the Therapeutic Efficacy of Parkinson's Disease by Advanced Nanoparticles

An upconversion nanoplatform based multi-effective theatment for Parkinson’s disease

Enhancing Neuroprotection in Mouse Model of Parkinson's Disease through Protein Nanosystem Conjugation with ApoE Peptide for miR-124 Delivery

Multifunctional Nanoprobe for the Delivery of Therapeutic siRNA and Real-Time Molecular Imaging of Parkinson’s Disease Biomarkers

Delivery of Biomimetic Liposomes via Meningeal Lymphatic Vessels Route for Targeted Therapy of Parkinson’s Disease